Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis

American Journal of Pathology

Volumn 167, Issue 3, 2005, Pages 695-704

  Nardacci, Roberta ^a   Antinori, Andrea ^a   Larocca, Luigi Maria ^b   Arena, Vincenzo ^b   Amendola, Alessandra ^a   Perfettini, Jean Luc ^d   Kroemer, Guido ^d   Piacentini, Mauro ^a,c  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; DNA FRAGMENT; GAG PROTEIN; I KAPPA B ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN P53; PROTEIN PUMA; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; DEMENTIA; FEMALE; FRONTAL CORTEX; GIANT CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; NICK END LABELING; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STATISTICAL ANALYSIS; SYNCYTIUM; VIRUS ENCEPHALITIS;

EID: 24044493578     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62044-5     Document Type: Article

References (47)

1. Gonzalez-Scarano F, Martin-Garcia J: The neuropathogenesis of AIDS. Nat Rev Immunol 2005, 5:69-81
2. Lawrence DM, Major EO: HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes Infect 2002, 4:301-308
3. Graham DI, Lantos PL: Greenfield's Neuropathology. New York, Oxford University Press, Inc., 1997, pp 15-25
4. Cornford ME, Holden JK, Boyd MC, Berry K, Vinters HV: Neuropathology of the acquired immune deficiency syndrome (AIDS): report of 39 autopsies from Vancouver, Br Columbia. Can J Neurol Sci 1992, 19:442-452
5. Kibayashi K, Mastri AR, Hirsch CS: Neuropathology of human immunodeficiency virus infection at different disease stages. Hum Pathol 1996, 27:637-642
6. Gartner S: HIV infection and dementia. Science 2000, 287:602-604
7. Kaul M, Garden GA, Lipton SA: Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994
8. Adle-Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C, Gray F: Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 1995, 21:218-227
9. Gelbard HA, James HJ, Sharer LR, Perry SW, Saito Y, Kazee AM, Blumberg BM, Epstein LG: Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 1995, 21:208-217
10. Petito CK, Roberts B: Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995, 146:1121-1130
11. Corasaniti MT, Piccirilli S, Paoletti A, Nistico R, Stringaro A, Malorni W, Finazzi-Agro A, Bagetta G: Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor. Neurosci Lett 2001, 312:67-70
12. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ: Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 1998, 95:14500-14505
13. Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL, Horuk R: Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 1998, 8:595-598
14. Corasaniti MT, Rotiroti D, Nappi G, Bagetta G: Neurobiological mediators of neuronal apoptosis in experimental neuro-AIDS. Toxicol Lett 2003, 139:199-206
15. Acquas E, Bachis A, Nosheny RL, Cernak I, Mocchetti I: Human immunodeficiency virus type 1 protein gp120 causes neuronal cell death in the rat brain by activating caspases. Neurotoxicol Res 2004, 5:605-615
16. Garden GA, Budd SL, Tsai E, Hanson L, Kaul M, D'Emilia DM, Friedlander RM, Yuan J, Masliah E, Lipton SA: Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J Neurosci 2002, 22:4015-4024
17. Garden GA, Quo W, Jayadev S, Tun C, Balcaitis S, Choi J, Montine TJ, Moller T, Morrison RS: HIV associated neurodegeneration requires p53 in neurons and microglia. FASEB J 2004, 18:1141-1143
18. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB: Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986, 83:7089-7093
19. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P: The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988, 239:586-592
20. Wiley CA, Achim C: Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neural 1994, 36:673-676
21. Lipton SA, Gendelman HE: Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995, 332:934-940
22. Lifson J, Coutre S, Huang E, Engleman E: Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. J Exp Med 1986, 164:2101-2106
23. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA: Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 1986, 322:470-474
24. Martin J, LaBranche CC, Gonzalez-Scarano F: Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate. J Virol 2001, 75:3568-3580
25. Johnston ER, Zijenah LS, Mutetwa S, Kantor R, Kittinunvorakoon C, Katzenstein DA: High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. J Virol 2003, 77:7682-7688
26. Polonis VR, de Souza MS, Darden JM, Chantakulkij S, Chuenchitra T, Nitayaphan S, Brown AE, Robb ML, Birx DL: Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients. J Virol 2003, 77:8570-8576
27. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D: CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997, 385:645-649
28. Zheng J, Thylin MR, Ghorpade A, Xiong H, Persidsky Y, Cotter R, Niemann D, Che M, Zeng YC, Gelbard HA, Shepard RB, Swartz JM, Gendelman HE: Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol 1999, 98:185-200
29. Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL: Chemokines and receptors in HIV encephalitis. AIDS 1998, 12:1021-1026
30. McManus CM, Weidenheim K, Woodman SE, Nunez J, Hesselgesser J, Nath A, Berman JW: Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol 2000, 156:1441-1453
31. Castedo M, Ferri KF, Blanco J, Roumier T, Larochette N, Barretina J, Amendola A, Nardacci R, Metivier D, Este JA, Piacentini M, Kroemer G: Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J Exp Med 2001, 194:1097-1110
32. Castedo M, Roumier T, Blanco J, Ferri KF, Barretina J, Tintignac LA, Andreau K, Perfettini JL, Amendola A, Nardacci R, Leduc P, Ingher DE, Druillennec S, Roques B, Leibovitch SA, Vilella-Bach M, Chen J, Este JA, Modjtahedi N, Piacentini M, Kroemer G: Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J 2002, 21:4070-4080
33. Perfettini JL, Roumier T, Castedo M, Larochette N, Boya P, Raynal B, Lazar V, Ciccosanti F, Nardacci R, Penninger J, Piacentini M, Kroemer G: NF-{kappa}B and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope. J Exp Med 2004, 199:629-640
34. Perfettini JL, Castedo M, Nardacci R, Ciccosanti F, Boya P, Roumier T, Larochette N, Piacentini M, Kroemer G: Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med 2005, 20:279-289
35. Rodolfo C, Mormone E, Matarrese P, Ciccosanti F, Farrace MG, Garofano E, Piredda L, Fimia GM, Malorni W, Piacentini M: "Tissue" transglutaminase is a multifunctional BH3-only protein. J Biol Chem 2004, 279:54783-54792
36. Nardacci R, Ciccosanti F, Falasca L, Lo Iacono O, Amendola A, Antonucci G, Piacentini M: Tissue transglutaminase in HCV infection. Cell Death Differ 2003, 10(Suppl 1):S79-S80
37. Nardacci R, Lo Iacono O, Ciccosanti F, Falasca L, Addesso M, Amendola A, Antonucci G, Craxi A, Fimia GM, Iadevaia V, Melino G, Ruco L, Tocci G, Ippolito G, Piacentini M: Transglutaminase type II plays a protective role in hepatic injury. Am J Pathol 2003, 162:1293-1303
38. Amendola A, Rodolfo C, Di Caro A, Ciccosanti F, Falasca L, Piacentini M: "Tissue" transglutaminase expression in HIV-infected cells: an enzyme with an antiviral effect? Ann NY Acad Sci 2001, 946:108-120
39. Amendola A, Fesus L, Piacentini M, Szondy Z: "Tissue" transglutaminase in AIDS. J Immunol Methods 2002, 265:145-159
40. Antinori A, Cingolani A, Giancola ML, Forbici F, De Luca A, Perno CF: Clinical implications for HIV-1 drug resistance in the neurological compartment. Scand J Infect Dis Suppl 2003, 35(Suppl 106):S41-S44
41. Fesus L, Piacentini M: Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 2002, 27:534-539
42. Cregan SP, Arbour NA, Maclaurin JG, Callaghan SM, Fortin A, Cheung EC, Guberman DS, Park DS, Slack RS: P53 activation domain 1 is essential for Puma upregulation and p53-mediated neuronal cell death. J Neurosci 2004, 24:10003-10012
43. Luciano CA, Pardo CA, McArthur JC: Recent developments in the HIV neuropathies. Curr Opin Neural 2003, 16:403-409
44. Dumaz N, Meek DW: Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 1999, 18:7002-7010
45. Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 2000, 408:307-310
46. Vousden KH: Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 2002, 1602:47-59
47. Mastroberardino PG, Iannicola C, Nardacci R, Bernassola F, De Laurenzi V, Melino G, Moreno S, Pavone F, Oliverio S, Fesus L, Piacentini M: 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ 2002, 9:873-880